Search

Rusfertide

Rusfertide is a hepcidin mimetic used to treat erythrocytosis in adults with polycythemia vera. … [L64098] Rusfertide is administered by subcutaneous injection and titrated to maintain hematocrit below 45%.

BMS-564929

So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause. … BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM).

N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine

Sensitivity to N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine may be identified with a clinical patch test.

SIG-001

SIG-001 is a cultured human retinal pigment epithelial cell line (ARPE-19) genetically modified with a non-viral vector to express B domain deleted human factor VIII protein, encapsulated within two-layer

Thymidine

[A274683] While it lacks significant anti-tumor activity on its own,[A274688] it has been extensively investigated for nearly a decade as a biochemical modulator to enhance the efficacy and reduce the

Vitis vinifera seed

Theobromine

It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension.

Montmorillonite

Cipepofol

GABA-A receptors, similar to the previously approved [propofol]. … [L63809] Haisco describes it as the first China-originated innovative intravenous anesthetic to enter the global market.

Ioxaglic acid

Ioxaglic acid has a low osmolarity and is associated with fewer side effects compared to older contrast agents [L1883].